NASDAQ
Cullinan Therapeutics, Inc. (CGEM) has a fcf yield of -28.76% as of Friday, May 29, 2026. This represents a 31.88% decrease compared to its 12-month average of -21.81%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.